Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
Most people see improvement over time , but some may have symptoms for several months
Scientists in a JAMA Ophthalmology study published in February 2025 reviewed data from over 16,000 patients with type 2 diabetes and found that those on semaglutide had a 32% higher risk of developing NAION compared to those who were not taking the drug
Tirzepatide is associated with pathways involved in appetite regulation and glucose control, which is why it is often discussed in the context of Tirzepatide weight loss and metabolic health support
[191] The retraction followed an investigation by The Sunday Times , which stated that Wakefield "acted dishonestly and irresponsibly"
Several long-term patients praise affordability, fast shipping, and reliable meds from specific pharmacies